The major global manufacturers of Pharmaceutical CDMO Market include: Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton, Piramal, Strides Pharma, NextPharma, Famar, Jubilant, Alcami, Euroapi, Eurofins, Avid Bioservices, BioVectra, CPL, .

The Global “Pharmaceutical CDMO Market” Research Report 2024 offers a comprehensive analysis of the market, including its size, share, trends, growth opportunities, and potential for expansion. The report segments the market by value and volume, focusing on manufacturing, application, type, and geography. It provides a geographic analysis covering regions such as North America, Europe, Asia-Pacific, and the Rest of the World. Additionally, the Pharmaceutical CDMO market within each region is further segmented by major countries, including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Pharmaceutical CDMO Market Analysis and Insights:

A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
Contract Pharmaceutical Manufacturing is part of CDMO, refers to accept commissioned from pharmaceutical companies, provide the service about API production, FDF production, packaging.
Pharmaceutical companies are likely to outsource a wide range of manufacturing related activities including – primary and secondary packaging, formulation, active ingredient manufacturing, labeling, clinical supplies, sterilization, manufacturing of chemical intermediates, etc. CDMOs support pharmaceutical companies at all stages of the process of making medicines: by providing services in the research and development stages, by offering support in manufacturing, and by providing formulating and finishing processes.
The global market for Pharmaceutical CDMO was estimated to be worth USD 128270 million in 2023 and is forecast to a readjusted size of USD 217220 million by 2030 with a CAGR of 7.7% during the forecast period 2024-2030
The key service providers of the Pharmaceutical CDMO in the world are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among which the market share of the top three service providers exceeds 10%, and Lonza is the largest service provider. The services provided by global pharmaceutical CDMO are mainly distributed in North America, Europe and China, among which the top three regions account for nearly 60% of the market share, and North America is currently the largest service provider. In terms of its service type, the growth rate of FDF CDMO is relatively fast. At present, the market share of API CDMO is the highest, more than 40%, followed by FDF CDMO, packaging CDMO and clinical CDMO. In terms of its application, pharmaceutical company are the largest application field, with a market share of more than 60%, followed by biotechnology company.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pharmaceutical CDMO manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers.

Some of the players in the research report include:

  • Lonza
  • Catalent
  • Thermo Fisher Scientific
  • Samsung Biologics
  • Fareva
  • WuXi AppTech
  • WuXi Biologics
  • Siegfried
  • FUJIFILM Diosynth Biotechnologies
  • Asymchem
  • Pfizer CentreOne
  • Delpharm
  • Recipharm
  • AGC Pharma Chemicals
  • Boehringer Ingelheim
  • Vetter
  • Curia
  • Aenova
  • Porton
  • Piramal
  • Strides Pharma
  • NextPharma
  • Famar
  • Jubilant
  • Alcami
  • Euroapi
  • Eurofins
  • Avid Bioservices
  • BioVectra
  • CPL

Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/27919734

Pharmaceutical CDMO segment by Type:

  • API CDMO
  • FDF CDMO
  • Packaging CDMO
  • Clinical CDMO

Pharmaceutical CDMO segment by Application:

  • Pharmaceutical Company
  • Biotechnology Company
  • Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2031.

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France

To Understand How Covid-19 Impact Is Covered in This Report – https://absolutereports.com/enquiry/request-covid19/27919734

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pharmaceutical CDMO market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Pharmaceutical CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pharmaceutical CDMO industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical CDMO.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapters included in this report:

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical CDMO manufacturers competitive landscape, price, output and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pharmaceutical CDMO by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pharmaceutical CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 5: Provides the analysis of various market segments according to product type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, revenue, , price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Analysis of sales channel, distributors and customers
  • Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

More.

Purchase this Report (Price 3950 USD for a Single-User License) – https://absolutereports.com/purchase/27919734

Detailed TOC of Global Pharmaceutical CDMO Market Research Report

1 Pharmaceutical CDMO Market Overview

1.1 Product Definition

1.2 Pharmaceutical CDMO by Type

1.2.1 Global Pharmaceutical CDMO Market Value Comparison by Type (2024-2030)

1.3 Pharmaceutical CDMO by Application

1.3.1 Global Pharmaceutical CDMO Market Value by Application (2024-2030)

1.4 Global Pharmaceutical CDMO Market Size Estimates and Forecasts

1.4.1 Global Pharmaceutical CDMO Revenue 2019-2030

1.4.2 Global Pharmaceutical CDMO Sales 2019-2030

1.4.3 Global Pharmaceutical CDMO Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pharmaceutical CDMO Market Competition by Manufacturers

2.1 Global Pharmaceutical CDMO Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pharmaceutical CDMO Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pharmaceutical CDMO Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Pharmaceutical CDMO, Industry Ranking, 2024 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pharmaceutical CDMO, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pharmaceutical CDMO, Product Type & Application

2.7 Global Key Manufacturers of Pharmaceutical CDMO, Date of Enter into This Industry

2.8 Global Pharmaceutical CDMO Market Competitive Situation and Trends

2.8.1 Global Pharmaceutical CDMO Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pharmaceutical CDMO Players Market Share by Revenue

2.8.3 Global Pharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pharmaceutical CDMO Market Scenario by Region

3.1 Global Pharmaceutical CDMO Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pharmaceutical CDMO Sales by Region: 2019-2030

3.2.1 Global Pharmaceutical CDMO Sales by Region: 2019-2024

3.2.2 Global Pharmaceutical CDMO Sales by Region: 2025-2030

3.3 Global Pharmaceutical CDMO Revenue by Region: 2019-2030

3.3.1 Global Pharmaceutical CDMO Revenue by Region: 2019-2024

3.3.2 Global Pharmaceutical CDMO Revenue by Region: 2025-2030

3.4 North America Pharmaceutical CDMO Market Facts & Figures by Country

3.4.1 North America Pharmaceutical CDMO Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pharmaceutical CDMO Sales by Country (2019-2030)

3.4.3 North America Pharmaceutical CDMO Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pharmaceutical CDMO Market Facts & Figures by Country

3.5.1 Europe Pharmaceutical CDMO Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pharmaceutical CDMO Sales by Country (2019-2030)

3.5.3 Europe Pharmaceutical CDMO Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pharmaceutical CDMO Market Facts & Figures by Region

3.6.1 Asia Pacific Pharmaceutical CDMO Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pharmaceutical CDMO Sales by Region (2019-2030)

3.6.3 Asia Pacific Pharmaceutical CDMO Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pharmaceutical CDMO Market Facts & Figures by Country

3.7.1 Latin America Pharmaceutical CDMO Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pharmaceutical CDMO Sales by Country (2019-2030)

3.7.3 Latin America Pharmaceutical CDMO Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pharmaceutical CDMO Market Facts & Figures by Country

3.8.1 Middle East and Africa Pharmaceutical CDMO Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pharmaceutical CDMO Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pharmaceutical CDMO Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pharmaceutical CDMO Sales by Type (2019-2030)

4.1.1 Global Pharmaceutical CDMO Sales by Type (2019-2024)

4.1.2 Global Pharmaceutical CDMO Sales by Type (2025-2030)

4.1.3 Global Pharmaceutical CDMO Sales Market Share by Type (2019-2030)

4.2 Global Pharmaceutical CDMO Revenue by Type (2019-2030)

4.2.1 Global Pharmaceutical CDMO Revenue by Type (2019-2024)

4.2.2 Global Pharmaceutical CDMO Revenue by Type (2025-2030)

4.2.3 Global Pharmaceutical CDMO Revenue Market Share by Type (2019-2030)

4.3 Global Pharmaceutical CDMO Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pharmaceutical CDMO Sales by Application (2019-2030)

5.1.1 Global Pharmaceutical CDMO Sales by Application (2019-2024)

5.1.2 Global Pharmaceutical CDMO Sales by Application (2025-2030)

5.1.3 Global Pharmaceutical CDMO Sales Market Share by Application (2019-2030)

5.2 Global Pharmaceutical CDMO Revenue by Application (2019-2030)

5.2.1 Global Pharmaceutical CDMO Revenue by Application (2019-2024)

5.2.2 Global Pharmaceutical CDMO Revenue by Application (2025-2030)

5.2.3 Global Pharmaceutical CDMO Revenue Market Share by Application (2019-2030)

5.3 Global Pharmaceutical CDMO Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Manufacture 1

6.1.1 Manufacture 1 Company Information

6.1.2 Manufacture 1 Description and Business Overview

6.1.3 Manufacture 1 Pharmaceutical CDMO Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Manufacture 1 Pharmaceutical CDMO Product Portfolio

6.1.5 Manufacture 1 Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pharmaceutical CDMO Industry Chain Analysis

7.2 Pharmaceutical CDMO Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pharmaceutical CDMO Production Mode & Process

7.4 Pharmaceutical CDMO Sales and Marketing

7.4.1 Pharmaceutical CDMO Sales Channels

7.4.2 Pharmaceutical CDMO Distributors

7.5 Pharmaceutical CDMO Customers

8 Pharmaceutical CDMO Market Dynamics

8.1 Pharmaceutical CDMO Industry Trends

8.2 Pharmaceutical CDMO Market Drivers

8.3 Pharmaceutical CDMO Market Challenges

8.4 Pharmaceutical CDMO Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Contact Us:

Absolute Reports

sales@absolutereports.com

Phone: US +1 (888) 690-5999

UK +44 8083 023308

Email: sales@absolutereports.com

Web: https://www.absolutereports.com

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media